LeMaitre Vascular
LMAT
139 hedge funds and large institutions have $355M invested in LeMaitre Vascular in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 52 increasing their positions, 46 reducing their positions, and 36 closing their positions.
3,200% more call options, than puts
Call options by funds: $231K | Put options by funds: $7K
13% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 46
5.14% less ownership
Funds ownership: 81.91% → 76.77% (-5.1%)
11% less funds holding
Funds holding: 156 → 139 (-17)
42% less capital invested
Capital invested by funds: $617M → $355M (-$262M)
44% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 36
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$4.8M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$3.23M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$2.85M |
| 4 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$1.81M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.56M |
Top Sellers
| 1 |
EIP
Epoch Investment Partners
New York
|
-$12M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$6.3M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$3.53M |
| 4 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$3.23M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$2.87M |
LMAT Hedge Fund Activity: Q4 2018 in Review
139 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q4 2018, worth a combined $355M — down 42% from $617M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of LMAT and 20 opened new positions — a net loss of 16 holders — while 46 trimmed existing stakes and 52 added.
The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $4.8M. The largest seller was Epoch Investment Partners, cutting an estimated $12M.
- 139 institutional investors held LeMaitre Vascular (LMAT) as of Q4 2018, down from 156 in Q3 2018.
- Funds reported $355M of LeMaitre Vascular stock for Q4 2018, down 42% quarter-over-quarter.
- 20 funds opened new LeMaitre Vascular positions in Q4 2018 and 36 closed out, a net change of -16 holders.
- The largest LeMaitre Vascular buyer in Q4 2018 was Kennedy Capital Management, an estimated $4.8M added.
- The largest LeMaitre Vascular seller in Q4 2018 was Epoch Investment Partners, an estimated $12M sold.
Based on aggregated 13F filings for Q4 2018.